Is Autologous Fecal Microbiota Transfer after Exclusive Enteral Nutrition in Pediatric Crohn's Disease Patients Rational and Feasible? Data from a Feasibility Test.
Hannes HoelzJeannine HeetmeyerAnastasia TsakmaklisAndreas HiergeistKolja SiebertFederica De ZenDeborah HäckerAmira MetwalyKlaus NeuhausAndré GessnerMaria J G T VehreschildDirk HallerTobias SchwerdPublished in: Nutrients (2023)
A high pathogen burden, low-diversity microbiota, and practical deficiencies of EEN-conditioned fecal material might render autologous capsule-FMT an unsuitable approach as maintenance therapy for pediatric CD patients.